ReproCELL Incorporated (FRA:6RC)

Market Cap	65.46M -34.0%
Revenue (ttm)	12.18M -25.0%
Net Income	-3.22M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.4860
Previous Close	0.5150
Day's Range	0.4860 - 0.4860
52-Week Range	0.4420 - 1.1000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About ReproCELL

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2003
• Employees: 99
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6RC

Financial Performance

Financial numbers in JPY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error